Popular Articles

Rexin-G Controls Tumor Growth And Improves Survival In Chemotherapy-Resistant Sarcoma And Osteosarcoma: Phase I/II And Phase II Studies, ASCO 2009
Epeius Biotechnologies announced the results of two related studies using Rexin-G, a tumor-targeted anti-cancer agent designed to seek-out and destroy metastatic cancers that have spread throughout the body. While Rexin-G is currently approved for the treatment of all solid tumors in the Republic of the Philippines, Epeius Biotech is conducting a series of advanced Phase I/II studies and a Phase II confirmatory trial in the U.S. The Phase I/II study evaluating the safety and efficacy of Rexin-G in chemotherapy-resistant metastatic bone and soft tissue sarcomas (ASCO Annual Meeting 2009, #10513) demonstrated that Rexin-G was well-tolerated with no dose-limiting toxicity. Moreover, Rexin-G exhibited dose-dependent efficacy in terms of tumor control rates, progression-free survival, and overall survival, thus validating both the efficiency of the tumor-targeting technology and the pharmacological mechanisms of action.
new payday loan lenders
OncoGenex Pharmaceuticals To Webcast ASCO Reception On May 30, 2009
OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that the Company will hold a live webcast and conference call of presentations made at an OncoGenex hosted reception during the 2009 American Society of Clinical Oncology Annual Meeting (ASCO) on Saturday, May 30, 2009. The webcast will begin at 7:10 p.m. EDT.
News of the day
International AIDS Conference Could Return To U.S. If Ban On HIV-Positive Visitors Is Reversed
The International AIDS Society (IAS) announced Thursday it is considering Washington, D.C., as the location for the 2012 biannual International AIDS Conference, Science Magazine"s blog, the ScienceInsider reports. "But before it holds the conference anywhere in the U.S., the federal government must change a law that bans HIV-infected people from entering the country," according to Science Insider. The conference has not been held in the U.S. since 1990, because the government banned people living with HIV from entering the U.S. "This long-standing law, which is contrary to all scientific evidence and human rights principles, is one of the U.S."s weakest spots in HIV policy," IAS President Julio Montaner said in a statement. The law has been repealed, but HHS still has HIV on the list of communicable diseases that bar entry. "In a statement to ScienceInsider, HHS said it has submitted "a notice of proposed rule-making to implement this change" to the Office of Management and Budget for its review," according to the blog (Cohen, ScienceInsider/Science, 6/11).
Diagnostics

Blood Tests And Better Communication Skills Could Cut Over-prescribing Of Antibiotics

Improving communications skills and the use of a simple blood test could help cut the growing number of inappropriate prescriptions of antibiotics, a joint Cardiff University trial has discovered. In a major new clinical trial, published in the British Medical Journal, a team of researchers from Cardiff University"s School of Medicine together with researchers from the Maastricht University Medical Centre in the Netherlands found those GPs in primary care who underwent training in advanced communications skills and those who made use of a simple blood test prescribed fewer antibiotics for lower respiratory tract infections, which generally do not respond to antibiotics. Professor Christopher Butler, Head of Department of Primary Care and Public Health at Cardiff University who led the trial, said: "As the problem of bacteria resistant to antibiotic treatment grows, researchers from around the world are seeking ways to improve the quality of antibiotic prescribing. Prescribing antibiotics only when patients will clearly benefit, reduces the pressure that drives antibiotic resistance. "Conditions like acute bronchitis account for some 80% of all lower respiratory tract infections and despite evidence of little or no benefit from antibiotics, the majority of these patients are still prescribed antibiotics. "We know that with the many pressures facing GPs, including worry about leaving pneumonia untreated, they often give patients "the benefit of the doubt" and prescribe antibiotics. Our clinical trial therefore sought to evaluate ways antibiotic prescribing could be reduced without adversely affecting patient recovery or satisfaction with care." The trial evaluated an "illness focussed" approach, where clinicians seek to better understand the patient"s illness experience and communicate more effectively about management, and a "disease focussed" approach, where clinicians focus on diagnosis, in this case, a simple point-of-care blood test. The trial randomised 20 general practices in the Netherlands, where 40 GPs managed 431 patients with lower respiratory tract infection. Dr Kerry Hood, Director of the South East Wales Trials Unit said, "The results showed that 54% of GPs practising according to usual care prescribed antibiotics, whereas 27% of those who had been trained in the advanced communication and 31% of the GPs who used the blood test methods did so. Only 23% of GPs who were trained in the advanced communication skills and who used the blood test prescribed antibiotics." Professor Butler added, "This international collaboration between primary care researchers from Cardiff and Maastricht has shown that both an "illness focussed" and a "disease focussed" approach were effective in reducing antibiotic prescribing, but the two approaches combined give the greatest benefit. We need to both communicate better and improve diagnosis to do the best for our patients and to preserve antibiotic effectiveness for our children. "Importantly, the results showed that prescribing fewer antibiotics did not mean that patients were unwell for longer. Patient"s recovery and satisfaction with care were not compromised by GPs not prescribing their patient antibiotics." Citation: "Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections" Jochen W L Cals, Christopher C Butler, Rogier M Hopstaken, Kerenza Hood, Geert-Jan Dinant British Medical Journal (BMJ), 2009; 338:b1374 Other Cardiff University


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):